Herceptin: A First Assault on Oncogenes that Launched a Revolution
- PMID: 31519311
- DOI: 10.1016/j.cell.2019.08.027
Herceptin: A First Assault on Oncogenes that Launched a Revolution
Abstract
This year's Lasker Clinical Research Award honors H. Michael Shepard, Dennis J. Slamon, and Axel Ullrich for their invention of Herceptin, the first monoclonal antibody that blocks a cancer-causing protein, and for its development as a life-saving therapy for women with breast cancer.
Copyright © 2019 Elsevier Inc. All rights reserved.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources